Abstract: Systems and methods for automatically organizing narrated media content based on a media description file are provided. For example, a media description file may be received with narrated media content. The media description file may include information about the narrated media content, such as entitlement levels associations between narrated media content items. The narrated media content may be automatically labeled based on the media description file. A personalized user interface may be generated based on the labeled narrated media content and user subscription tiers.

Abstract: A lateral transverse discharge spark plug (10) which consists of a cylindrical metallic shell (20) having a tubular ceramic insulator (22), including an insulator attachment end (28) enclosed therein. An offset center electrode (30) is surrounded by the ceramic insulator. The offset center electrode has a firing tip (36) extending from the insulator distal end. A ground electrode 38 is attached to a side of the metallic shell, and the ground electrode has a first gap (#1GAP) distanced from the offset center electrode. The offset center electrode and the ground electrode protrude from the cylindrical metallic shell attachment end and the end of said ceramic insulator in a terminally aligned orientation. A second embodiment utilizing a center electrode (31) is also disclosed.

Abstract: This invention is directed generally to hydroxamic acid and amide compounds (including salts of such compounds), and, more particularly, to aryl- and heteroaryl-arylsulfonylmethyl hydroxamic acids and amides that, inter alia, inhibit protease activity, particularly matrix metalloproteinase (also known as “matrix metalloprotease” or “MMP”) activity and/or aggrecanase activity. These compounds generally correspond in structure to Formula I: wherein A1, A2, A3, E1, E2, E3, and E4 are as defined in this patent. This invention also is directed to compositions of such compounds, intermediates for the syntheses of such compounds, methods for making such compounds, and methods for treating conditions associated with MMP activity and/or aggrecanase activity, particularly pathological conditions.

Abstract: This invention is directed generally to proteinase (also known as “protease”) inhibitors, and, more particularly, to piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids that, inter alia, inhibit matrix metalloproteinase (also known as “matrix metalloprotease” or “MMP”) activity and/or aggrecanase activity. Such hydroxamic acids generally correspond in structure to the following formula: (wherein A1, A2, Y, E1, E2, E3, and Rx are as defined in this specification), and further include salts of such compounds. This invention also is directed to compositions of such hydroxamic acids, intermediates for the syntheses of such hydroxamic acids, methods for making such hydroxamic acids, and methods for treating conditions (particularly pathological conditions) associated with MMP activity and/or aggrecanase activity.